中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 上海药物代谢研究中心
Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole

文献类型：期刊论文

作者Liu, Xiaoyun3,4; Zhang, Yifan3; Chen, Qian2; Zhan, Yan3; Wang, Quanren1; Hu, Chaoying2; Yu, Chen2; Guo, Zitao3; Chen, Xiaoyan3,4; Zhong, Dafang3,4
刊名JOURNAL OF CLINICAL PHARMACOLOGY
出版日期2018-03
卷号58期号:3页码:347-356
ISSN号0091-2700
关键词apatinib rifampin itraconazole drug-drug interaction pharmacokinetics
DOI10.1002/jcph.1016
文献子类Article
英文摘要Apatinib is a small-molecule tyrosine kinase inhibitor that has been approved for the treatment of patients with advanced-stage gastric cancer or gastroesophageal junction cancer who have progressed or recurred after at least 2 kinds of systemic chemotherapy. In vitro data indicate that cytochrome P450 (CYP) 3A4 is the primary CYP isoenzyme involved in the metabolism of apatinib. Pharmacokinetic drug-drug interactions of apatinib and (1) a CYP3A4 inducer (rifampin) or (2) a CYP3A inhibitor (itraconazole) were clinically evaluated in healthy volunteers. Compared with the single administration of apatinib, its coadministration with rifampin resulted in a 5.6-fold plasma clearance (CL/F) and 83% decrease in plasma AUC(0-t) of apatinib. By contrast, coadministration with itraconazole reduced the CL/F of apatinib by 40% and increased its AUC(0-t) by 75%. In summary, a strong CYP3A4 inducer (rifampin) had a strong effect (>5-fold) on the clinical pharmacokinetics of apatinib, whereas a strong CYP3A inhibitor (itraconazole 100 mg once a day) had a weak effect (1.25-to 2-fold). Whether these effects are of clinical significance needs further research and information about the exposure-safety and exposure-efficacy relationship of apatinib.
WOS关键词INCREASES PLASMA-CONCENTRATIONS ; KETOCONAZOLE ; CLARITHROMYCIN ; TRANSPORTERS ; INHIBITION ; LOVASTATIN ; CANCER
资助项目National Natural Science Foundation of China[81521005]
WOS研究方向Pharmacology & Pharmacy
语种英语
出版者WILEY
WOS记录号WOS:000424394300010
源URL[http://119.78.100.183/handle/2S10ELR8/279882]  
专题上海药物代谢研究中心
通讯作者Zhong, Dafang
作者单位1.Jiangsu Hengrui Med Co Ltd, Lianyungang, Peoples R China
2.Shanghai Xuhui Cent Hosp, Shanghai, Peoples R China;
3.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China;
4.Univ Chinese Acad Sci, Beijing, Peoples R China;
推荐引用方式
GB/T 7714		 Liu, Xiaoyun,Zhang, Yifan,Chen, Qian,et al. Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole[J]. JOURNAL OF CLINICAL PHARMACOLOGY,2018,58(3):347-356.
APA Liu, Xiaoyun.,Zhang, Yifan.,Chen, Qian.,Zhan, Yan.,Wang, Quanren.,...&Zhong, Dafang.(2018).Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole.JOURNAL OF CLINICAL PHARMACOLOGY,58(3),347-356.
MLA Liu, Xiaoyun,et al."Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole".JOURNAL OF CLINICAL PHARMACOLOGY 58.3(2018):347-356.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。